HIGHLIGHTS
- who: Neuro-Oncology Advances and colleagues from the Division of Evolution and Genomic Medicine, Centre for Genomic Medicine, Academic Health Science Centre, University of, Mary`swho had resided or were residing in the United Kingdom have published the Article: Neuro-Oncology Advances, in the Journal: (JOURNAL)
- what: The study shows a 6% 20-year risk of CNS malignancy/malignant progression an accurate assessment of malignancy risk that can be used when discussing radiation treatment with NF2 patients. There are concerns not just about the potential increased risks of malignant progression (MP) in the often multifocal . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.